{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:08:06Z","timestamp":1788826086548,"version":"build-2803163510"},"reference-count":175,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.htct.2026.106456","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:33:18Z","timestamp":1777033998000},"page":"106456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Criteria for referring pediatric and adult patients with hematological diseases to palliative care: Consensus of the Brazilian Association of Hematology, hemotherapy and cell therapy (2025)"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7316-4829","authenticated-orcid":false,"given":"Amanda Pifano Soares","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia Emerick Mendes","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Ferreira de Mesquita","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo de Mello Novita","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Munari","family":"Magnus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa de Miranda","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3252-9067","authenticated-orcid":false,"given":"J\u00falia Alvarenga","family":"Petrocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana de Fran\u00e7a Ribeiro","family":"Gonzaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tathiana Rodrigues Peres","family":"Braz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita de C\u00e1ssia Ros\u00e1rio","family":"Cavalheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara Andrea Pires Afonso","family":"Reina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8068-7986","authenticated-orcid":false,"given":"Sandra Regina","family":"Loggetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Lobo de Figueiredo","family":"Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia Maria Meira","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato Sampaio","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos S\u00e9rgio","family":"Chiattone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia Tietsche de Moraes","family":"Hungria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8656-8374","authenticated-orcid":false,"given":"Carmino Ant\u00f4nio","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Ferreira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2971-7203","authenticated-orcid":false,"given":"Paula","family":"de Melo Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2026.106456_bib0001","series-title":"Global atlas of palliative care","author":"Connor","year":"2020"},{"key":"10.1016\/j.htct.2026.106456_bib0002","series-title":"WHOQOL user manual","year":"2012"},{"key":"10.1016\/j.htct.2026.106456_bib0003","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jpainsymman.2020.04.027","article-title":"Redefining palliative care-A new consensus-based definition","volume":"60","author":"Radbruch","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.htct.2026.106456_bib0004","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/asheducation-2015.1.471","article-title":"When and why should patients with hematologic malignancies see a palliative care specialist?","author":"LeBlanc","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.htct.2026.106456_bib0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update","volume":"35","author":"Ferrell","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0006","series-title":"Improving out comes in haematological cancers: the manual","author":"Eastwood","year":"2003"},{"key":"10.1016\/j.htct.2026.106456_bib0007","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2026.106456_bib0008","doi-asserted-by":"crossref","first-page":"e746","DOI":"10.1016\/S2666-7568(21)00213-0","article-title":"Palliative care of patients with haematological malignancies: strategies to overcome difficulties via integrated care","volume":"2","author":"Wedding","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.htct.2026.106456_bib0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12885-017-3207-7","article-title":"A systematic review of prognostic factors at the end of life for people with a hematological malignancy","volume":"17","author":"Button","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0010","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/0269216310391692","article-title":"Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data","volume":"25","author":"Howell","year":"2011","journal-title":"Palliat Med"},{"key":"10.1016\/j.htct.2026.106456_bib0011","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1200\/JCO.2017.76.2146","article-title":"Keeping expectations in check with immune checkpoint inhibitors","volume":"36","author":"Temel","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0012","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/pon.4414","article-title":"Shared decision-making and providing information among newly diagnosed patients with hematological malignancies and their informal caregivers: Not \"one-size-fits-all\"","volume":"26","author":"Rood","year":"2017","journal-title":"Psychooncology"},{"key":"10.1016\/j.htct.2026.106456_bib0013","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cncr.30325","article-title":"Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists\/oncologists in the United States: Findings from the MPN Landmark survey","volume":"123","author":"Mesa","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0014","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1634\/theoncologist.2018-0317","article-title":"Patient-clinician discordance in perceptions of treatment risks and benefits in older patients with acute myeloid leukemia","volume":"24","author":"El-Jawahri","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.htct.2026.106456_bib0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clml.2019.12.004","article-title":"Early palliative care: a necessary intervention for patients ineligibile to approved potentially life-saving CAR T-cell therapy","volume":"20","author":"Potenza","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.htct.2026.106456_bib0016","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1089\/jpm.2019.0311","article-title":"Illness understanding and advance care planning in patients with advanced lymphoma","volume":"23","author":"Trevino","year":"2020","journal-title":"J Palliat Med"},{"key":"10.1016\/j.htct.2026.106456_bib0017","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1200\/JOP.2014.001537","article-title":"End-of-life care for blood cancers: a series of focus groups with hematologic oncologists","volume":"10","author":"Odejide","year":"2014","journal-title":"J Oncol Pr"},{"key":"10.1016\/j.htct.2026.106456_bib0018","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjh.18286","article-title":"Early integration of palliative care for patients with haematological malignancies","volume":"199","author":"Shaulov","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2026.106456_bib0019","doi-asserted-by":"crossref","first-page":"j878","DOI":"10.1136\/bmj.j878","article-title":"Palliative care from diagnosis to death","volume":"356","author":"Murray","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.htct.2026.106456_bib0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/asheducation-2015.1.479","article-title":"Early integration of palliative care into the care of patients with cancer","author":"Thienprayoon","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.htct.2026.106456_bib0021","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/0269216319840604","article-title":"Haematology and palliative care: the needs are out there","volume":"33","author":"Porta-Sales","year":"2019","journal-title":"Palliat Med"},{"key":"10.1016\/j.htct.2026.106456_bib0022","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.2016.16786","article-title":"Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial","volume":"316","author":"El-Jawahri","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.htct.2026.106456_bib0023","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1200\/JCO.24.00542","article-title":"Palliative care for patients with cancer: ASCO guideline update","volume":"42","author":"Sanders","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0024","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bjhh.2014.09.003","article-title":"Palliative care in pediatric hematological oncology patients: experience of a tertiary hospital","volume":"36","author":"Valadares","year":"2014","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.htct.2026.106456_bib0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cnur.2010.03.003","article-title":"Sickle cell disease: an opportunity for palliative care across the life span","volume":"45","author":"Wilkie","year":"2010","journal-title":"Nurs Clin North Am"},{"key":"10.1016\/j.htct.2026.106456_bib0026","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1741","article-title":"Response to suffering of the seriously Ill child: a history of palliative care for children","volume":"145","author":"Sisk","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.htct.2026.106456_bib0027","first-page":"113","article-title":"Total care. Recent advances in the treatment of children with cancer","volume":"80","author":"Smith","year":"1979","journal-title":"J Kans Med Soc"},{"key":"10.1016\/j.htct.2026.106456_bib0028","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0145-2134(83)90048-0","article-title":"Humanizing paediatric care","volume":"7","author":"Lewis","year":"1983","journal-title":"Child Abuse Negl"},{"key":"10.1016\/j.htct.2026.106456_bib0029","unstructured":"in Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life (2015)."},{"key":"10.1016\/j.htct.2026.106456_bib0030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM200002033420506","article-title":"Symptoms and suffering at the end of life in children with cancer","volume":"342","author":"Wolfe","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2026.106456_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30081","article-title":"Differences in palliative opportunities across diagnosis groups in children with cancer","volume":"70","author":"Ebelhar","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30561","article-title":"Embracing paediatric palliative care in paediatric oncology from diagnosis onwards","volume":"70","author":"Lacerda","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0033","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/02692163231163258","article-title":"Palliative care referral criteria and application in pediatric illness care: a scoping review","volume":"37","author":"Bernier Carney","year":"2023","journal-title":"Palliat Med"},{"key":"10.1016\/j.htct.2026.106456_bib0034","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jpainsymman.2014.12.010","article-title":"Feasibility of conducting a palliative care randomized controlled trial in children with advanced cancer: assessment of the PediQUEST study","volume":"49","author":"Dussel","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.htct.2026.106456_bib0035","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2013.51.5981","article-title":"Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial","volume":"32","author":"Wolfe","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0036","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jpainsymman.2021.12.009","article-title":"Normalization of symptoms in advanced child cancer: the PediQUEST-response case study","volume":"63","author":"Requena","year":"2022","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.htct.2026.106456_bib0037","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MPH.0b013e3181f46a65","article-title":"Managing painful procedures in children with cancer","volume":"33","author":"Hockenberry","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0038","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2023.05.010","article-title":"The development methods of official GRADE articles and requirements for claiming the use of GRADE - A statement by the GRADE guidance group","volume":"159","author":"Schunemann","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.htct.2026.106456_bib0039","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejon.2019.05.005","article-title":"Patients' experiences and social support needs following the diagnosis and initial treatment of acute leukemia - A qualitative study","volume":"41","author":"Norskov","year":"2019","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.htct.2026.106456_bib0040","series-title":"in Hematologia e hemoterapia pedi\u00e1trica-um guia pr\u00e1tico","author":"Flor Park","year":"2022"},{"key":"10.1016\/j.htct.2026.106456_bib0041","unstructured":"Vakiti A, R. S., Mewawalla P. (StatPearls Publishing, Treasure Island (FL), [Updated 2024 Apr 27].)."},{"key":"10.1016\/j.htct.2026.106456_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2019.150959","article-title":"Integration of palliative care into acute myeloid leukemia care","volume":"35","author":"Webb","year":"2019","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.htct.2026.106456_bib0043","first-page":"897","article-title":"The relationship between emotional well-being and understanding of prognosis in patients with acute myeloid leukemia (AML)","volume":"30","author":"Singh","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0044","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ajh.27246","article-title":"Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia","volume":"99","author":"Pratz","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.htct.2026.106456_bib0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12904-021-00776-5","article-title":"Current status of intensive end-of-life care in children with hematologic malignancy: a population-based study","volume":"20","author":"Yotani","year":"2021","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.htct.2026.106456_bib0046","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1182\/blood-2014-11-551481","article-title":"How I treat acute lymphoblastic leukemia in older adolescents and young adults","volume":"125","author":"Curran","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0047","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/hematology.2021000226","article-title":"Acute lymphoblastic leukemia in older adults: curtain call for conventional chemotherapy?","volume":"2021","author":"Luskin","year":"2021","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.htct.2026.106456_bib0048","first-page":"229","article-title":"Progress and Prospects in Pediatric Leukemia","volume":"46","author":"Madhusoodhan","year":"2016","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1016\/j.htct.2026.106456_bib0049","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.leukres.2013.02.009","article-title":"Symptom burden and supportive care in patients with acute leukemia","volume":"37","author":"Zimmermann","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.htct.2026.106456_bib0050","article-title":"2015 ASCO annual meeting","volume":"33","author":"LeBlanc","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0051","first-page":"163","article-title":"Emotion And Symptom-focused Engagement (EASE): a randomized phase II trial of an integrated psychological and palliative care intervention for patients with acute leukemia","volume":"28","author":"Rodin","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0052","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamaoncol.2020.6343","article-title":"Effectiveness of integrated palliative and oncology care for patients with acute myeloid leukemia: a randomized clinical trial","volume":"7","author":"El-Jawahri","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0053","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1002\/cncr.33886","article-title":"Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial","volume":"127","author":"Nelson","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0054","article-title":"2024 ASCO Annual Meeting II","volume":"42","author":"El-Jawahri","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0055","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ajh.26984","article-title":"Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Garcia-Manero","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.htct.2026.106456_bib0056","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.annonc.2020.11.002","article-title":"Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(dagger\u2606)","volume":"32","author":"Fenaux","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2018.09.001","article-title":"Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it","volume":"34","author":"Zeidan","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.htct.2026.106456_bib0058","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0059","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.htct.2026.106456_bib0060","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2024025271","article-title":"How I treat higher-risk MDS","author":"Mina","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0061","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1182\/bloodadvances.2022008360","article-title":"Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS registry study","volume":"7","author":"Stojkov","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.htct.2026.106456_bib0062","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11899-016-0352-z","article-title":"Palliative and end-of-life care in myelodysplastic syndromes","volume":"11","author":"Nickolich","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.htct.2026.106456_bib0063","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.2094.2094","article-title":"A patient-reported outcome measure for symptoms and symptom burden of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)","volume":"126","author":"Williams","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0064","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.leukres.2007.10.015","article-title":"Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey","volume":"32","author":"Steensma","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.htct.2026.106456_bib0065","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1182\/blood.V108.11.5505.5505","article-title":"Quality of life and myelodysplasia","volume":"108","author":"Prommer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0066","first-page":"246","article-title":"Costs and quality of life in patients with myelodysplastic syndromes","volume":"3","author":"Lucioni","year":"2013","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.htct.2026.106456_bib0067","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.21037\/apm-21-276","article-title":"Early integrated palliative care for haematology cancer patients-the impact on symptom burden in Hong Kong","volume":"10","author":"Chan","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.htct.2026.106456_bib0068","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/cncr.29913","article-title":"Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database","volume":"122","author":"Fletcher","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0069","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00277-016-2649-3","article-title":"Causes of death in 2877 patients with myelodysplastic syndromes","volume":"95","author":"Nachtkamp","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.htct.2026.106456_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.htct.2019.03.001","article-title":"Guideline on myeloproliferative neoplasms: associacao Brazileira de Hematologia, Hemoterapia e Terapia Cellular: project guidelines: associacao Medica Brazileira - 2019","volume":"1","author":"Tavares","year":"2019","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.htct.2026.106456_bib0071","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood-2011-04-347575","article-title":"Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population","volume":"118","author":"Efficace","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0072","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3324\/haematol.2020.247767","article-title":"Fatigue in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: predictors and the relationship with physical activity","volume":"106","author":"Janssen","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2026.106456_bib0073","series-title":"Oxford textbook of palliative medicine","year":"2021"},{"key":"10.1016\/j.htct.2026.106456_bib0074","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s11864-023-01084-1","article-title":"Advancing palliative care integration in hematology: building upon existing evidence","volume":"24","author":"Robbins-Welty","year":"2023","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0075","first-page":"1097","article-title":"Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison","volume":"21","author":"Phillips","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0076","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.htct.2020.10.966","article-title":"Myeloproliferative neoplasm symptom assessment form - total symptom score (MPN-SAF TSS) questionnaire: translation, cultural adaptation and validation to Brazilian Portuguese","volume":"44","author":"Guarana","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.htct.2026.106456_bib0077","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41375-024-02341-4","article-title":"Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial","volume":"38","author":"Efficace","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.htct.2026.106456_bib0078","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s12325-022-02398-6","article-title":"The economic burden of chronic myeloid leukemia in patients with later lines: findings from a real-world analysis in Italy","volume":"40","author":"Breccia","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.htct.2026.106456_bib0079","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.htct.2026.106456_bib0080","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1182\/bloodadvances.2020001767","article-title":"End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies","volume":"4","author":"Egan","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.htct.2026.106456_bib0081","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2011-01-328955","article-title":"The myeloproliferative neoplasm symptom assessment form (MPN-SAF): international prospective validation and reliability trial in 402 patients","volume":"118","author":"Scherber","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0082","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cncr.22365","article-title":"The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients","volume":"109","author":"Mesa","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0083","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12885-016-2208-2","article-title":"Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey","volume":"16","author":"Mesa","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0084","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1002\/cam4.3380","article-title":"Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition","volume":"9","author":"Padrnos","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.htct.2026.106456_bib0085","unstructured":"Ali H., C M., \u03c3 \u00de, Dunbar A., George T.I., Green S., et al. NCCN Guidelines Version 2.2024 Myeloproliferative Neoplasms Patient advocate (2024). https:\/\/www.nccn.org\/home\/member."},{"key":"10.1016\/j.htct.2026.106456_bib0086","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1200\/JCO.2012.42.3863","article-title":"Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs","volume":"30","author":"Emanuel","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0087","first-page":"521","article-title":"Myeloproliferative Neoplasms: Translating New Discoveries Into Better Outcomes, Better Quality of Life","volume":"31","author":"Padrnos","year":"2017","journal-title":"Oncol (Willist Park)"},{"key":"10.1016\/j.htct.2026.106456_bib0088","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajh.26857","article-title":"Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.htct.2026.106456_bib0089","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.leukres.2017.06.001","article-title":"Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis","volume":"59","author":"Masarova","year":"2017","journal-title":"Leuk Res"},{"key":"10.1016\/j.htct.2026.106456_bib0090","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.mayocp.2017.05.010","article-title":"Leukemic transformation in myeloproliferative neoplasms: a literature review on risk, characteristics, and outcome","volume":"92","author":"Yogarajah","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.htct.2026.106456_bib0091","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.htct.2026.106456_bib0092","doi-asserted-by":"crossref","DOI":"10.33448\/rsd-v13i4.45502","article-title":"Perfil epidemiol\u00f3gico dos casos de linfoma n\u00e3o Hodgkin no Brazil","volume":"13","author":"Melo","year":"2024","journal-title":"Res Soc Dev"},{"key":"10.1016\/j.htct.2026.106456_bib0093","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1182\/blood-2024-212117","article-title":"Global incidence, mortality and risk factors of hodgkins and non-hodgkins lymphoma 1990-2021: a global health data study","volume":"144","author":"Kundu","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0094","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/ajh.27470","article-title":"Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management","volume":"99","author":"Ansell","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.htct.2026.106456_bib0095","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/hematology.2020000100","article-title":"Strategies for introducing palliative care in the management of relapsed or refractory aggressive lymphomas","author":"Odejide","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.htct.2026.106456_bib0096","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/08258597211073226","article-title":"Prevalence and predictors of palliative care utilization among hospitalized patients with diffuse large B-cell lymphoma","volume":"38","author":"Jackson","year":"2023","journal-title":"J Palliat Care"},{"key":"10.1016\/j.htct.2026.106456_bib0097","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10238-024-01407-y","article-title":"Characterization of cells and mediators associated with pruritus in primary cutaneous T-cell lymphomas","volume":"24","author":"Hu","year":"2024","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.htct.2026.106456_bib0098","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpainsymman.2017.08.030","article-title":"Comparing the palliative care needs of patients with hematologic and solid malignancies","volume":"55","author":"Hochman","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.htct.2026.106456_bib0099","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/0269216315583446","article-title":"Establishing psychosocial palliative care standards for children and adolescents with cancer and their families: an integrative review","volume":"30","author":"Weaver","year":"2016","journal-title":"Palliat Med"},{"key":"10.1016\/j.htct.2026.106456_bib0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/pbc.24851","article-title":"Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma","volume":"61","author":"Harker-Murray","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0101","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","article-title":"Long-term outcomes following CAR T cell therapy: what we know so far","volume":"20","author":"Cappell","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0102","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00277-017-2958-1","article-title":"Impact of cachexia on outcomes in aggressive lymphomas","volume":"96","author":"Karmali","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.htct.2026.106456_bib0103","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/jcsm.12837","article-title":"Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B-cell lymphoma","volume":"12","author":"Go","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.htct.2026.106456_bib0104","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1200\/JCO.18.02386","article-title":"Palliative and end-of-life care for patients with hematologic malignancies","volume":"38","author":"El-Jawahri","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0105","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jpainsymman.2021.03.014","article-title":"Outcomes of specialty palliative care interventions for patients with hematologic malignancies: a systematic review","volume":"62","author":"Elliott","year":"2021","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.htct.2026.106456_bib0106","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jpm.2020.0006","article-title":"Early palliative care services and end-of-life care in medicare beneficiaries with hematologic malignancies: a population-based retrospective cohort study","volume":"24","author":"Rao","year":"2021","journal-title":"J Palliat Med"},{"key":"10.1016\/j.htct.2026.106456_bib0107","unstructured":"Institute, N. C. Cancer Stat Facts: Myeloma, https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html (2025)."},{"key":"10.1016\/j.htct.2026.106456_bib0108","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ijc.31664","article-title":"Global cancer incidence in older adults, 2012 and 2035: A population-based study","volume":"144","author":"Pilleron","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0109","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/0269216319830017","article-title":"The experiences and needs of primary family caregivers of patients with multiple myeloma: A qualitative analysis","volume":"33","author":"Quinoa-Salanova","year":"2019","journal-title":"Palliat Med"},{"key":"10.1016\/j.htct.2026.106456_bib0110","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/bloodadvances.2024015575","article-title":"Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma","volume":"9","author":"O'Donnell","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.htct.2026.106456_bib0111","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","article-title":"Health related quality of life in a nationally representative sample of haematological patients","volume":"83","author":"Johnsen","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.htct.2026.106456_bib0112","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/0269216319833588","article-title":"Symptoms and anxiety predict declining health-related quality of life in multiple myeloma: a prospective, multi-centre longitudinal study","volume":"33","author":"Ramsenthaler","year":"2019","journal-title":"Palliat Med"},{"key":"10.1016\/j.htct.2026.106456_bib0113","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.0902-4441.2003.00195.x","article-title":"Myeloma study, interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences","volume":"72","author":"Gulbrandsen","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.htct.2026.106456_bib0114","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0609.2012.01831.x","article-title":"Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry","volume":"89","author":"Mols","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.htct.2026.106456_bib0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2011.08574.x","article-title":"Guidelines for supportive care in multiple myeloma 2011","volume":"154","author":"Snowden","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2026.106456_bib0116","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jpainsymman.2017.04.012","article-title":"Is early palliative care feasible in patients with multiple myeloma?","volume":"54","author":"Porta-Sales","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.htct.2026.106456_bib0117","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/spcare-2023-004524","article-title":"Early palliative care versus usual haematological care in multiple myeloma: retrospective cohort study","volume":"14","author":"Giusti","year":"2024","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.htct.2026.106456_bib0118","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12885-016-2410-2","article-title":"The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study","volume":"16","author":"Ramsenthaler","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0119","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2026.106456_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13071991","article-title":"Role of palliative care in the supportive management of AL amyloidosis-a review","volume":"13","author":"Habib","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.htct.2026.106456_bib0121","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1182\/blood-2005-11-4385","article-title":"Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL","volume":"107","author":"Palladini","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0122","series-title":"Oxford textbook of palliative medicine","volume":"0","author":"LeBlanc","year":"2021"},{"key":"10.1016\/j.htct.2026.106456_bib0123","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.291.19.2335","article-title":"Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma","volume":"291","author":"Syrjala","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.htct.2026.106456_bib0124","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1002\/cncr.31709","article-title":"What do transplant physicians think about palliative care? A national survey study","volume":"124","author":"El-Jawahri","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0125","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/s41409-021-01281-2","article-title":"Palliative care for patients undergoing stem cell transplant: intervention components and supportive care measures","volume":"56","author":"Nelson","year":"2021","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.htct.2026.106456_bib0126","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3324\/haematol.2016.150250","article-title":"Late effects of blood and marrow transplantation","volume":"102","author":"Inamoto","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2026.106456_bib0127","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/cncr.29818","article-title":"Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation","volume":"122","author":"El-Jawahri","year":"2016","journal-title":"Cancer"},{"issue":"341","key":"10.1016\/j.htct.2026.106456_bib0128","first-page":"e341","article-title":"Post-traumatic stress symptoms in hematopoietic stem cell transplant recipients","volume":"27","author":"Fenech","year":"2021","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.htct.2026.106456_bib0129","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1200\/JCO.2017.73.2800","article-title":"Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial","volume":"35","author":"El-Jawahri","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0130","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29424","article-title":"Perceptions of specialty palliative care and its role in pediatric stem cell transplant: a multidisciplinary qualitative study","volume":"69","author":"Collins","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0131","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpainsymman.2023.06.005","article-title":"Integration of palliative care in hematopoietic cell transplant: pediatric patient and parent needs and attitudes","volume":"66","author":"Levine","year":"2023","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.htct.2026.106456_bib0132","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2024.107460","article-title":"Protocol for multi-site randomized trial of inpatient palliative care for patients with hematologic malignancies undergoing hematopoietic stem cell transplantation","volume":"138","author":"Yang","year":"2024","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.htct.2026.106456_bib0133","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/bloodadvances.2024014574","article-title":"Factors associated with early quality-of-life response to palliative care during hematopoietic cell transplantation","volume":"9","author":"Newcomb","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.htct.2026.106456_bib0134","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/bmt.2016.164","article-title":"A scoping review of caregiver burden during allogeneic HSCT: lessons learned and future directions","volume":"51","author":"Applebaum","year":"2016","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.htct.2026.106456_bib0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40164-024-00573-9","article-title":"New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies","volume":"13","author":"Yang","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.htct.2026.106456_bib0136","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102479","article-title":"Toxicities following CAR-T therapy for hematological malignancies","volume":"111","author":"Hernani","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.htct.2026.106456_bib0137","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1097\/HS9.0000000000000185","article-title":"CAR-T Cell therapy in diffuse large B cell lymphoma: hype and hope","volume":"3","author":"Hopfinger","year":"2019","journal-title":"Hemasphere"},{"key":"10.1016\/j.htct.2026.106456_bib0138","doi-asserted-by":"crossref","first-page":"18741","DOI":"10.18632\/aging.104058","article-title":"A comprehensive analysis of the fatal toxic effects associated with CD19 CAR-T cell therapy","volume":"12","author":"Cai","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.htct.2026.106456_bib0139","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1182\/blood.2024024166","article-title":"Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA adverse events reporting system","volume":"143","author":"Elsallab","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0140","unstructured":"Moore, C. A. & Krishnan, K. in StatPearls (2025)."},{"key":"10.1016\/j.htct.2026.106456_bib0141","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107441","article-title":"Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes \/germline predisposition syndromes: back under the microscope","volume":"137","author":"Elghetany","year":"2024","journal-title":"Leuk Res"},{"key":"10.1016\/j.htct.2026.106456_bib0142","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.seminhematol.2017.04.004","article-title":"Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia","volume":"54","author":"Savage","year":"2017","journal-title":"Semin Hematol"},{"key":"10.1016\/j.htct.2026.106456_bib0143","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1007\/s00431-023-05093-y","article-title":"Optimizing diagnostic methods and stem cell transplantation outcomes in pediatric bone marrow failure: a 50-year single center experience","volume":"182","author":"Vissers","year":"2023","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.htct.2026.106456_bib0144","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood.2022017739","article-title":"Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances","volume":"141","author":"Reilly","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0145","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s13023-024-03490-6","article-title":"Diagnosis of Diamond-Blackfan anemia in adulthood: case series and review of the literature","volume":"19","author":"Versino","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.htct.2026.106456_bib0146","article-title":"Congenital amegakaryocytic thrombocytopenia - Not a single disease","volume":"34","author":"Germeshausen","year":"2021","journal-title":"Best Pr Res Clin Haematol"},{"key":"10.1016\/j.htct.2026.106456_bib0147","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/shem.2002.31913","article-title":"Kostmann syndrome and severe congenital neutropenia","volume":"39","author":"Zeidler","year":"2002","journal-title":"Semin Hematol"},{"key":"10.1016\/j.htct.2026.106456_bib0148","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00277-019-03681-3","article-title":"Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and\/or paroxysmal nocturnal haemoglobinuria (QLQ-AA\/PNH)-a report on phase III","volume":"98","author":"Niedeggen","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.htct.2026.106456_bib0149","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.2019000940","article-title":"Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria","volume":"136","author":"Sun","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41687-018-0032-y","article-title":"Value of transfusion independence in severe aplastic anemia from patients' perspectives - a discrete choice experiment","volume":"2","author":"Pickard","year":"2017","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.htct.2026.106456_bib0151","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2024.100181","article-title":"Treatment response and its predictors of immunosuppressive therapy in patients with severe or very severe aplastic anemia","volume":"22","author":"Somprasertkul","year":"2024","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.htct.2026.106456_bib0152","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood.V130.Suppl_1.678.678","article-title":"A retrospective chart review to assess burden of illness among patients with severe aplastic anemia with insufficient response to immunosuppressive therapy","volume":"130","author":"Peffault De Latour","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0153","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1182\/blood-2023-182810","article-title":"Quality of life analysis in patients with AA using the QLQ-AA\/PNH-54 at initial diagnosis of AA - a registry based analysis","volume":"142","author":"Walter","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0154","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101158","article-title":"Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape","volume":"64","author":"Waheed","year":"2024","journal-title":"Blood Rev"},{"key":"10.1016\/j.htct.2026.106456_bib0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.htct.2020.06.006","article-title":"Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria","volume":"43","author":"Cancado","year":"2021","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.htct.2026.106456_bib0156","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.htct.2026.106456_bib0157","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jcap.12077","article-title":"Pain, coping, and sleep in children and adolescents with sickle cell disease","volume":"27","author":"Graves","year":"2014","journal-title":"J Child Adolesc Psychiatr Nurs"},{"key":"10.1016\/j.htct.2026.106456_bib0158","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/jpm.2018.0649","article-title":"Acute care utilization at end of life in sickle cell disease: highlighting the need for a palliative approach","volume":"23","author":"Johnston","year":"2020","journal-title":"J Palliat Med"},{"key":"10.1016\/j.htct.2026.106456_bib0159","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/asheducation-2008.1.466","article-title":"Pain management in sickle cell disease: palliative care begins at birth?","author":"Benjamin","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.htct.2026.106456_bib0160","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1182\/blood-2019-128884","article-title":"Analysis of the eligibility of patients with sickle cell disease for palliative care","volume":"134","author":"Toro da Silva","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.htct.2026.106456_bib0161","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/0886260517691521","article-title":"Interpersonal violence exposure and chronic pain in adult sickle cell patients","volume":"35","author":"Ford","year":"2020","journal-title":"J Interpers Violence"},{"key":"10.1016\/j.htct.2026.106456_bib0162","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/jpm.2015.0268","article-title":"Palliative care teams as advocates for adults with sickle cell disease","volume":"19","author":"Ajayi","year":"2016","journal-title":"J Palliat Med"},{"key":"10.1016\/j.htct.2026.106456_bib0163","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4103\/1658-354X.140867","article-title":"Behavioral impact of sickle cell disease in young children with repeated hospitalization","volume":"8","author":"Bakri","year":"2014","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.htct.2026.106456_bib0164","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/00302228221116513","article-title":"Death is as much part of life as living\": attitudes and experiences preparing for death from older adults with sickle cell disease","volume":"90","author":"Oyedeji","year":"2025","journal-title":"Omega (Westport)"},{"key":"10.1016\/j.htct.2026.106456_bib0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/j.pain.0000000000003009","article-title":"A cognitive-behavioral digital health intervention for sickle cell disease pain in adolescents: a randomized, controlled, multicenter trial","volume":"165","author":"Palermo","year":"2024","journal-title":"Pain"},{"key":"10.1016\/j.htct.2026.106456_bib0166","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/hematology.2024000561","article-title":"End-of-life care for people with sickle cell disease: barriers to and facilitators of high-quality care","volume":"2024","author":"Patel","year":"2024","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.htct.2026.106456_bib0167","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30315","article-title":"Efficacy of non-pharmacological interventions to reduce pain in children with sickle cell disease: a systematic review","volume":"70","author":"van Veelen","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.htct.2026.106456_bib0168","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2218","article-title":"Improving care for sickle cell pain crisis using a multidisciplinary approach","volume":"143","author":"Balsamo","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.htct.2026.106456_bib0169","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.15537\/smj.2020.10.25386","article-title":"Outcomes of multidisciplinary team interventions in the management of sickle cell disease patients with opioid use disorders. A retrospective cohort study","volume":"41","author":"Al Zahrani","year":"2020","journal-title":"Saudi Med J"},{"key":"10.1016\/j.htct.2026.106456_bib0170","article-title":"Psychological therapies for the management of chronic and recurrent pain in children and adolescents","volume":"9","author":"Fisher","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.htct.2026.106456_bib0171","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057361","article-title":"Inpatient palliative care use by patients with sickle cell disease: a retrospective cross-sectional study","volume":"12","author":"Nwogu-Onyemkpa","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.htct.2026.106456_bib0172","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6050054","article-title":"Hemophilia care in the pediatric age","volume":"6","author":"Bertamino","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.htct.2026.106456_bib0173","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.htct.2022.06.007","article-title":"Early integration of palliative care in hematology: an urgency for patients, a challenge for physicians","volume":"44","author":"Ferraz","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.htct.2026.106456_bib0174","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.htct.2022.07.006","article-title":"There's nothing left to do!\": the interface between hematology and palliative care","volume":"45","author":"Ferreira","year":"2023","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.htct.2026.106456_bib0175","unstructured":"2011 Public Opinion Research on Palliative Care - A Report Based on Research by Public Opinion Strategies, https:\/\/media.capc.org\/filer_public\/18\/ab\/18ab708c-f835-4380-921d-fbf729702e36\/2011-public-opinion-research-on-palliative-care.pdf. (2011)."}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:23:45Z","timestamp":1788823425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926002038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":175,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2531137926002038"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106456","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Criteria for referring pediatric and adult patients with hematological diseases to palliative care: Consensus of the Brazilian Association of Hematology, hemotherapy and cell therapy (2025)","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106456"}}